Literature DB >> 15339702

Acquired angioedema: a new target for rituximab?

Panayiotis D Ziakas, Stavroula Giannouli, Erasmia Psimenou, Kompoti Evangelia, Athanasios G Tzioufas, Michalis Voulgarelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15339702

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  3 in total

Review 1.  C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies?

Authors:  R J Lock; M M Gompels
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

2.  A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.

Authors:  Delphine Gobert; Romain Paule; Denise Ponard; Pierre Levy; Véronique Frémeaux-Bacchi; Laurence Bouillet; Isabelle Boccon-Gibod; Christian Drouet; Stéphane Gayet; David Launay; Ludovic Martin; Arsène Mekinian; Véronique Leblond; Olivier Fain
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

3.  A Case of Acquired Angioedema with Low C1 Inhibitor (C1-INH) Associated with Splenic Marginal Zone Lymphoma.

Authors:  Nizar N Abdel-Samad; Judit S Kokai
Journal:  Am J Case Rep       Date:  2019-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.